IBO
Impact BioMedical, Inc.
AMEX: IBO · HEALTHCARE · BIOTECHNOLOGY
$0.66
-2.59% today
Updated 2026-05-01
Market cap
$71.16M
P/E ratio
—
P/S ratio
2,223.81x
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$0 – $2
Volume
5.4M
Impact BioMedical, Inc. (IBO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-320341.00 | $-71993.00 | $-121985.00 | $-1143.00 | $-3.25M | $-4.33M | $-2.85M | $-5.64M | $-1.89M |
| Capital expenditures | $0.00 | $0.00 | $1529.00 | $0.00 | $276000.00 | $95680.00 | $18000.00 | $0.00 | $0.00 |
| Depreciation | — | — | $255.00 | — | $69856.00 | $266398.00 | $1.12M | $1.61M | — |
| Stock-based comp | $94000.00 | — | — | — | — | $903537.00 | $0.00 | $19000.00 | $13000.00 |
| Free cash flow | $-320341.00 | $-71993.00 | $-123514.00 | $-1143.00 | $-3.53M | $-4.43M | $-2.87M | $-5.64M | $-1.89M |
| Investing cash flow | $-225000.00 | $225000.00 | $-26529.00 | $-804.00 | $-42929.00 | $-2.09M | $-15000.00 | $2876.00 | — |
| Financing cash flow | $209513.00 | — | $16085.00 | $1901.00 | $3.38M | $7.01M | $2.87M | $8.51M | — |
| Dividends paid | — | — | — | — | $410000.00 | $410000.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |